ID
27344
Description
Study ID: 103534 Clinical Study ID: 103534 Study Title: Evaluate the immunogenicity, reactogenicity, safety of 4 different formulations of GSK Biologicals' conjugate vaccine (MenACWY) vs 1 dose of MenC-CRM197 or Mencevax™ ACWY in children aged 12-14 months & 3-5 years Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00196976 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed clinical study under GSK sponsorship. The product that is studied in this clinical study, together with the rights to the data and results generated, has been transferred by GSK to Pfizer. GSK’s Clinical Study Register is no longer maintained for this study. To request access to clinical study data from Pfizer, go here: http://www.pfizer.com/research/clinical_trials/trial_data_and_results Generic Name: Meningococcal Serogroups A, C, W-135 and Y-Tetanus Toxoid Conjugate Vaccine Trade Name: Nimenrix Study Indication: Infections, Meningococcal Booster Vaccination Only for subjects who are part of the group with the selected MenACWY-TT formulation and the control group.) “Subjects enrolled at 3 – 5 years of age”
Lien
http://www.pfizer.com/research/clinical_trials/trial_data_and_results
Mots-clés
Versions (1)
- 08/11/2017 08/11/2017 -
Détendeur de droits
Pfizer
Téléchargé le
8 novembre 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Meningococcal Infections Vaccination in children NCT00196976
Workbook 2 Study Conclusion Stage 2
- StudyEvent: ODM
Description
Follow-up studies Stage 2
Alias
- UMLS CUI-1
- C0016441
Description
Follow-up study participation
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0016441
- UMLS CUI [1,2]
- C2348568
Description
Follow-up study participation
Type de données
text
Alias
- UMLS CUI [1,1]
- C3274571
- UMLS CUI [1,2]
- C2348568
Description
STUDY CONCLUSION STAGE 2
Alias
- UMLS CUI-1
- C1707478
- UMLS CUI-2
- C0008976
- UMLS CUI-3
- C0042210
Description
Elimination criteria
Type de données
boolean
Alias
- UMLS CUI [1]
- C0680251
Description
Elimination criteria
Type de données
text
Alias
- UMLS CUI [1,1]
- C0680251
- UMLS CUI [1,2]
- C1521902
Description
Administrative Documentation
Alias
- UMLS CUI-1
- C1320722
Description
Investigators signature
Type de données
text
Alias
- UMLS CUI [1]
- C2346576
Description
Signature Date
Type de données
date
Alias
- UMLS CUI [1]
- C0807937
Description
Printed Investigator's name:
Type de données
text
Alias
- UMLS CUI [1]
- C2826892
Similar models
Workbook 2 Study Conclusion Stage 2
- StudyEvent: ODM
C2348568 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,2])
C0008976 (UMLS CUI-2)
C0042210 (UMLS CUI-3)
C1521902 (UMLS CUI [1,2])